Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Antenatal milk expression for women with diabetes in pregnancy

In The Lancet, Della Forster and colleagues1 present the findings from their randomised trial investigating the safety of antenatal breastmilk expression in women with diabetes in pregnancy (the Diabetes and Antenatal Milk Expression [DAME] trial). Antenatal milk expression has gained popularity despite little scientific study of its benefits or harms. As Forster and colleagues1 note, only two small pilot studies have been previously done,2,3 yet this nascent practice is commonly recommended by lactation consultants and others working in the lactation field.